Reduction of Nasopharyngeal Carriage of Streptococcus pneumoniae after Administration of a 9-Valent Pneumococcal Conjugate Vaccine to Toddlers Attending Day Care Centers
A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up p...
Saved in:
Published in | The Journal of infectious diseases Vol. 185; no. 7; pp. 927 - 936 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chicago, IL
The University of Chicago Press
01.04.2002
University of Chicago Press |
Subjects | |
Online Access | Get full text |
ISSN | 0022-1899 1573-6613 1537-6613 |
DOI | 10.1086/339525 |
Cover
Abstract | A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged ⩽36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group. |
---|---|
AbstractList | A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged < or =36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group. A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged ⩽36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group. A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged less than or equal to 36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group. A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged < or =36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group.A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged < or =36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group. |
Author | Dagan, Ron Givon-Lavi, Noga Yagupsky, Pablo Fraser, Drora Guy, Lior Zamir, Orly Sikuler-Cohen, Merav Janco, Jacob |
Author_xml | – sequence: 1 givenname: Ron surname: Dagan fullname: Dagan, Ron email: rdagan@bgumail.bgu.ac.il organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel – sequence: 2 givenname: Noga surname: Givon-Lavi fullname: Givon-Lavi, Noga organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel – sequence: 3 givenname: Orly surname: Zamir fullname: Zamir, Orly organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel – sequence: 4 givenname: Merav surname: Sikuler-Cohen fullname: Sikuler-Cohen, Merav organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel – sequence: 5 givenname: Lior surname: Guy fullname: Guy, Lior organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel – sequence: 6 givenname: Jacob surname: Janco fullname: Janco, Jacob organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel – sequence: 7 givenname: Pablo surname: Yagupsky fullname: Yagupsky, Pablo organization: Clinical Microbiology Laboratories, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel – sequence: 8 givenname: Drora surname: Fraser fullname: Fraser, Drora organization: Epidemiology Department, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13596877$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11920317$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0suO0zAUBuAIDWI6A7wByCxgRcAnTuJkWZVLQeUiGCo0G8t1Too7qR1sR2IeibfEbTodCQmx8uL_8ss-OWfJibEGk-Qh0BdAq_IlY3WRFXeSCRScpWUJ7CSZUJplKVR1fZqceb-hlOas5PeSU4A6owz4JPn9BZtBBW0NsS35KL3tf0h3bdYoOzKTzmm5xl30NTjsg1VWqcGT3uCwtUZLJLIN6Mi02WqjfXDypkuSOl3KDk0gn_d69-mu1JrNsJYByVIqpQ2SYMmFbZoOnSfTENA02qzJK3m9uwCSWayI0f3kbis7jw8O53ny7c3ri9k8XXx6-242XaQqz7KQcqghh4rzVYucVVxisypKULJZlfkqw7qmWYPQ1i0FVXDYi6yCrGJc1k3LzpNnY2_v7M8BfRBb7RV2nTRoBy84FDkvM_5fCFUOAAwifHyAw2qLjeid3sYZi5u_EMHTA5A-jqh10ijtbx0r6jK-KLrno1POeu-wFUqH_cDj3HUngIrdMohxGW4veOTHxr_hkxHaof-3eTSajQ_WHRWjwDjjVczTMY9LgL-OuXRXooygEPPvl-Ly_Xw5KxYL8YH9Adjk1v0 |
CODEN | JIDIAQ |
CitedBy_id | crossref_primary_10_1056_NEJMe068038 crossref_primary_10_1038_s41598_023_31820_4 crossref_primary_10_1097_01_inf_0000143645_58215_f0 crossref_primary_10_1097_INF_0000000000001341 crossref_primary_10_1371_journal_pone_0030548 crossref_primary_10_1056_NEJMoa022823 crossref_primary_10_1128_CVI_00117_10 crossref_primary_10_1016_j_vaccine_2014_12_023 crossref_primary_10_1016_j_ijid_2019_02_003 crossref_primary_10_1586_14760584_7_9_1367 crossref_primary_10_1128_JCM_43_6_2656_2661_2005 crossref_primary_10_1016_S0264_410X_03_00361_X crossref_primary_10_1086_593339 crossref_primary_10_1136_ebn_6_1_e1 crossref_primary_10_1111_j_1541_0420_2012_01826_x crossref_primary_10_4161_hv_26109 crossref_primary_10_1016_j_vaccine_2005_08_029 crossref_primary_10_1097_01_inf_0000435805_25366_64 crossref_primary_10_1016_j_vaccine_2015_02_012 crossref_primary_10_1016_j_vaccine_2006_11_032 crossref_primary_10_1016_j_vaccine_2009_04_009 crossref_primary_10_1086_422651 crossref_primary_10_1128_IAI_00601_10 crossref_primary_10_1038_s41598_017_08717_0 crossref_primary_10_1093_cid_cis371 crossref_primary_10_1097_01_inf_0000154326_77617_3e crossref_primary_10_1007_s00520_009_0804_2 crossref_primary_10_1097_INF_0b013e31824de9f6 crossref_primary_10_1128_IAI_71_11_6199_6204_2003 crossref_primary_10_1128_IAI_72_9_5031_5040_2004 crossref_primary_10_1080_21645515_2017_1287640 crossref_primary_10_1186_s12879_019_4254_2 crossref_primary_10_1186_1471_2334_9_102 crossref_primary_10_1080_21645515_2016_1261772 crossref_primary_10_1592_phco_2005_25_9_1193 crossref_primary_10_1016_j_vaccine_2005_10_053 crossref_primary_10_1016_j_vaccine_2014_06_091 crossref_primary_10_1016_S1473_3099_08_70281_0 crossref_primary_10_1086_596064 crossref_primary_10_1371_journal_pone_0068940 crossref_primary_10_1002_14651858_CD004977_pub2 crossref_primary_10_1128_CMR_00018_12 crossref_primary_10_1053_j_spid_2004_01_011 crossref_primary_10_1097_INF_0b013e318168d28a crossref_primary_10_2165_00003495_200565020_00005 crossref_primary_10_1016_j_micpath_2010_02_009 crossref_primary_10_1586_14760584_5_4_553 crossref_primary_10_1016_j_medmal_2011_02_001 crossref_primary_10_1016_S0031_3939_11_70577_7 crossref_primary_10_1016_j_anl_2021_07_003 crossref_primary_10_1016_j_jim_2004_11_006 crossref_primary_10_1186_1471_2334_13_357 crossref_primary_10_1016_S0140_6736_10_62225_8 crossref_primary_10_1016_j_mimet_2008_08_010 crossref_primary_10_1111_j_1469_0691_2009_02775_x crossref_primary_10_1371_journal_pone_0072198 crossref_primary_10_1016_j_coi_2012_05_005 crossref_primary_10_1111_j_1442_200X_2010_03212_x crossref_primary_10_1371_journal_pone_0027102 crossref_primary_10_1097_00006454_200210000_00016 crossref_primary_10_3109_00365548_2011_601754 crossref_primary_10_1172_JCI33947 crossref_primary_10_1080_14760584_2019_1627207 crossref_primary_10_1093_aje_kwm076 crossref_primary_10_1089_mdr_2009_0056 crossref_primary_10_1586_erv_09_78 crossref_primary_10_1111_j_1469_0691_2006_01502_x crossref_primary_10_1080_00365540500321512 crossref_primary_10_1016_j_ijmm_2004_04_004 crossref_primary_10_1086_423379 crossref_primary_10_1016_j_vaccine_2008_07_016 crossref_primary_10_1097_01_inf_0000069760_65826_f2 crossref_primary_10_1016_j_vaccine_2014_03_017 crossref_primary_10_1186_s12879_020_05674_4 crossref_primary_10_1111_biom_12473 crossref_primary_10_1128_JCM_41_1_386_392_2003 crossref_primary_10_1016_j_cpem_2013_04_005 crossref_primary_10_1016_j_vaccine_2015_11_012 crossref_primary_10_1097_INF_0b013e3181a78185 crossref_primary_10_1093_cid_ciz1164 crossref_primary_10_1097_01_inf_0000069761_11093_c3 crossref_primary_10_1016_S1473_3099_10_70318_2 crossref_primary_10_1097_01_inf_0000109221_50972_53 crossref_primary_10_1586_eri_09_112 crossref_primary_10_1016_S1473_3099_15_70007_1 crossref_primary_10_1097_INF_0b013e31814da70c crossref_primary_10_1086_382696 crossref_primary_10_1016_S0140_6736_03_13772_5 crossref_primary_10_1016_j_vaccine_2010_02_065 crossref_primary_10_1016_j_vaccine_2017_07_019 crossref_primary_10_1098_rspb_2013_1939 crossref_primary_10_1007_s00467_008_0989_5 crossref_primary_10_1097_01_inf_0000195784_27503_f0 crossref_primary_10_1007_s11908_008_0031_x crossref_primary_10_1586_14760584_5_4_517 crossref_primary_10_1016_S0882_4010_03_00048_2 crossref_primary_10_1542_peds_112_4_862 crossref_primary_10_1099_mic_0_28394_0 crossref_primary_10_1097_INF_0b013e3181658c5c crossref_primary_10_1016_j_annemergmed_2006_10_026 crossref_primary_10_1128_JCM_40_11_3903_3908_2002 crossref_primary_10_1086_522984 crossref_primary_10_1007_s12275_014_3583_5 crossref_primary_10_1517_14712598_2012_636348 crossref_primary_10_1016_j_vaccine_2009_05_062 crossref_primary_10_1016_S1696_2818_03_71587_X crossref_primary_10_1016_S1473_3099_06_70520_5 crossref_primary_10_1186_1471_2334_6_14 crossref_primary_10_1586_14760584_5_5_651 crossref_primary_10_1016_j_femsim_2004_03_013 crossref_primary_10_1128_CVI_00248_12 crossref_primary_10_1016_j_vaccine_2013_06_040 crossref_primary_10_1136_bmjopen_2018_027233 crossref_primary_10_1016_j_vaccine_2005_08_092 crossref_primary_10_1586_eri_09_132 crossref_primary_10_1128_IAI_73_10_7043_7046_2005 crossref_primary_10_1371_journal_ppat_1000159 crossref_primary_10_1016_j_vaccine_2012_08_012 crossref_primary_10_1016_S0140_6736_06_69614_1 crossref_primary_10_1128_IAI_72_10_5807_5813_2004 crossref_primary_10_1016_j_vaccine_2020_04_050 crossref_primary_10_1186_1471_2334_5_41 crossref_primary_10_1016_j_vaccine_2007_04_088 crossref_primary_10_1016_j_femsre_2004_05_002 crossref_primary_10_1016_j_idc_2005_05_008 crossref_primary_10_1016_j_vaccine_2003_11_038 crossref_primary_10_1128_spectrum_00591_24 crossref_primary_10_1086_428585 crossref_primary_10_1016_j_epidem_2008_07_001 crossref_primary_10_1016_j_vaccine_2012_03_058 crossref_primary_10_1097_01_inf_0000243163_85163_a8 crossref_primary_10_3201_eid1007_030612 crossref_primary_10_1016_j_anpedi_2012_05_026 crossref_primary_10_1016_S0011_393X_02_80074_1 crossref_primary_10_1093_infdis_jis447 crossref_primary_10_1080_14760584_2020_1750377 crossref_primary_10_1371_journal_pmed_1001107 crossref_primary_10_1086_432721 crossref_primary_10_1016_j_arcped_2004_11_013 crossref_primary_10_1016_j_meegid_2007_07_011 crossref_primary_10_1586_14760584_7_1_83 crossref_primary_10_1111_j_1365_2249_2004_02628_x crossref_primary_10_1016_j_vaccine_2009_09_113 crossref_primary_10_1128_JCM_44_3_999_1017_2006 crossref_primary_10_1016_j_vaccine_2004_12_014 crossref_primary_10_1111_j_1469_0691_2004_00869_x crossref_primary_10_1038_nbt728 crossref_primary_10_1097_INF_0b013e3181a06303 crossref_primary_10_1128_CVI_00344_08 crossref_primary_10_1086_527401 crossref_primary_10_1586_erv_12_53 crossref_primary_10_1128_JCM_00265_07 crossref_primary_10_1016_S0031_3955_03_00025_7 crossref_primary_10_1016_S1473_3099_18_30660_1 crossref_primary_10_1097_INF_0000000000003223 crossref_primary_10_1007_s40121_021_00406_w crossref_primary_10_1016_j_diagmicrobio_2012_11_021 crossref_primary_10_1128_JCM_42_10_4449_4452_2004 crossref_primary_10_1097_MRM_0b013e32833a345f crossref_primary_10_1177_2333794X221078698 crossref_primary_10_1016_S0095_4543_03_00004_6 crossref_primary_10_1093_cid_cis554 crossref_primary_10_1016_j_clim_2024_110295 crossref_primary_10_3389_fimmu_2022_1078904 crossref_primary_10_1016_j_vaccine_2011_09_074 crossref_primary_10_1542_peds_113_3_443 crossref_primary_10_3947_ic_2016_48_4_257 crossref_primary_10_1097_MCC_0000000000000338 crossref_primary_10_1002_eji_200839091 crossref_primary_10_1586_14760584_4_2_207 crossref_primary_10_1111_j_1469_0691_2006_01544_x crossref_primary_10_1128_IAI_73_11_7718_7726_2005 crossref_primary_10_1097_01_inf_0000145478_36236_1e crossref_primary_10_1371_journal_pcbi_1006333 crossref_primary_10_1371_journal_pmed_1001017 crossref_primary_10_1080_21645515_2015_1095414 crossref_primary_10_4236_wjv_2013_32007 crossref_primary_10_1016_j_yapd_2006_04_015 crossref_primary_10_1186_1471_2334_10_90 crossref_primary_10_1097_00001432_200406000_00002 crossref_primary_10_1016_j_vaccine_2004_05_003 crossref_primary_10_1097_INF_0b013e31825cb9f9 crossref_primary_10_1128_IAI_72_5_2659_2670_2004 crossref_primary_10_1177_00034894051140S110 crossref_primary_10_1089_mdr_2008_0782 crossref_primary_10_1097_01_inf_0000257425_24492_11 crossref_primary_10_1371_journal_pone_0085459 crossref_primary_10_1371_journal_pmed_0020015 crossref_primary_10_1016_S1473_3099_04_00938_7 crossref_primary_10_1111_j_1469_0691_2006_1502_1_x crossref_primary_10_1016_j_vaccine_2004_02_038 crossref_primary_10_1128_CVI_05369_11 crossref_primary_10_1016_j_bbmt_2019_10_006 crossref_primary_10_1016_j_vaccine_2006_09_011 crossref_primary_10_1093_cid_cit428 crossref_primary_10_1097_INF_0b013e3181b78e6e crossref_primary_10_1046_j_1365_3083_2003_01292_x crossref_primary_10_2165_00148581_200810020_00002 crossref_primary_10_1016_j_vaccine_2015_01_003 crossref_primary_10_1016_j_vaccine_2008_05_073 crossref_primary_10_1016_j_mimet_2007_04_008 crossref_primary_10_1371_journal_pone_0195799 crossref_primary_10_1016_j_vaccine_2003_09_036 crossref_primary_10_1097_00006454_200308001_00003 crossref_primary_10_1038_mi_2015_5 crossref_primary_10_1080_17513758_2011_592548 crossref_primary_10_1097_00020840_200312000_00002 crossref_primary_10_1016_j_ijporl_2005_06_022 crossref_primary_10_1016_j_jmii_2017_08_022 crossref_primary_10_1186_s13104_019_4330_0 crossref_primary_10_1371_journal_pone_0049143 crossref_primary_10_1542_peds_2007_2017 crossref_primary_10_1097_INF_0000000000002452 crossref_primary_10_1371_journal_pone_0114286 crossref_primary_10_1016_j_vaccine_2010_03_030 crossref_primary_10_1097_01_idc_0000230541_02089_8c crossref_primary_10_1016_j_jiac_2019_12_009 crossref_primary_10_1128_JCM_00665_09 crossref_primary_10_1086_504802 crossref_primary_10_1371_journal_pone_0082047 crossref_primary_10_1016_j_ijporl_2004_04_008 crossref_primary_10_1007_s10096_005_1313_y crossref_primary_10_1016_j_vaccine_2021_04_068 crossref_primary_10_1086_587941 crossref_primary_10_1097_INF_0000000000001800 crossref_primary_10_1097_INF_0000000000000717 crossref_primary_10_1128_JCM_43_1_74_83_2005 crossref_primary_10_1097_00020840_200210000_00001 crossref_primary_10_1073_pnas_0600636103 crossref_primary_10_1128_AAC_48_6_2206_2213_2004 crossref_primary_10_1016_j_idc_2015_07_009 crossref_primary_10_1542_peds_2007_2703 crossref_primary_10_4236_wjv_2015_52011 crossref_primary_10_1186_1471_2431_10_4 crossref_primary_10_2165_00019053_200624020_00004 crossref_primary_10_1542_pir_30_5_155 crossref_primary_10_1038_srep14952 crossref_primary_10_1016_j_diagmicrobio_2013_03_028 crossref_primary_10_1016_S0399_077X_03_00002_7 crossref_primary_10_1016_j_vaccine_2004_06_009 |
ContentType | Journal Article |
Copyright | Copyright 2002 Infectious Diseases Society of America 2002 by the Infectious Diseases Society of America 2002 2002 INIST-CNRS |
Copyright_xml | – notice: Copyright 2002 Infectious Diseases Society of America – notice: 2002 by the Infectious Diseases Society of America 2002 – notice: 2002 INIST-CNRS |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QL C1K 7X8 |
DOI | 10.1086/339525 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE Bacteriology Abstracts (Microbiology B) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1573-6613 1537-6613 |
EndPage | 936 |
ExternalDocumentID | 11920317 13596877 10_1086_339525 10.1086/339525 30137378 ark_67375_HXZ_ZJHVC5LL_M |
Genre | Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -DZ -~X ..I .2P .55 .GJ .I3 .XZ .ZR 08P 0R~ 123 1TH 29K 2AX 2WC 36B 3O- 4.4 48X 53G 5GY 5RE 5VS 5WD 70D 85S AABZA AACGO AACZT AAHBH AAHTB AAJKP AAMVS AANCE AAOGV AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWTL ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPEJ ABPLY ABPPZ ABPQP ABPTD ABQLI ABQNK ABTLG ABVGC ABWST ABXSQ ABXVV ABZBJ ACGFO ACGFS ACGOD ACHIC ACPRK ACUFI ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADQXQ ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFZL AFHKK AFIYH AFOFC AFXAL AFYAG AGINJ AGKEF AGORE AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AI. AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN AQVQM ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BR6 BSCLL BTRTY BVRKM C45 CDBKE CS3 CZ4 D-I DAKXR DCCCD DIK DILTD DU5 D~K EBS ECGQY EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H5~ HAR HQ3 HTVGU HW0 HZ~ IH2 IOX IPSME J21 J5H JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B LSO LU7 MHKGH MJL ML0 MVM N4W N9A NEJ NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TR2 VH1 W2D W8F WH7 X7H X7M Y6R YAYTL YKOAZ YXANX ZGI ZXP ~91 AASNB ADACV ADJQC ADRIX AFXEN DOOOF ESX JSODD M49 1KJ 41~ AAFWJ AAJQQ AAPGJ AAWDT AAYOK AAYXX ABDPE ABSMQ ACFRR ACPQN ACUTJ ACVCV ACZBC ADMTO AEKPW AFFQV AFQQW AFSHK AGKRT AGMDO AHGBF AJDVS APJGH AQDSO AQKUS AVNTJ BZKNY CITATION EIHJH H13 MBLQV OBFPC O~Y P0- TMA ZE2 IQODW CGR CUY CVF ECM EIF NPM VXZ YIF 7QL C1K 7X8 |
ID | FETCH-LOGICAL-c422t-719141877bfe7387aedb561cadb64b2e9902de1f9f01c57187aed2812837a9df3 |
ISSN | 0022-1899 |
IngestDate | Sun Sep 28 07:29:53 EDT 2025 Sun Sep 28 11:38:24 EDT 2025 Wed Feb 19 01:30:20 EST 2025 Mon Jul 21 09:11:53 EDT 2025 Thu Apr 24 23:09:47 EDT 2025 Tue Jul 01 03:23:27 EDT 2025 Wed Sep 11 04:50:58 EDT 2024 Fri Jun 20 02:31:44 EDT 2025 Sat Sep 20 11:01:51 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Human Preschool age Immunoprotection Vaccination Infant Asymptomatic Nasopharynx Polyvalent vaccine Streptococcus pneumoniae Infection Streptococcaceae Streptococcal infection Bacteriosis Bacteria Micrococcales Carrier |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c422t-719141877bfe7387aedb561cadb64b2e9902de1f9f01c57187aed2812837a9df3 |
Notes | istex:8A56C0FA2AE68916B453BD91FB668B1A1228859A ark:/67375/HXZ-ZJHVC5LL-M ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
PMID | 11920317 |
PQID | 18411131 |
PQPubID | 23462 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_71547627 proquest_miscellaneous_18411131 pubmed_primary_11920317 pascalfrancis_primary_13596877 crossref_citationtrail_10_1086_339525 crossref_primary_10_1086_339525 oup_primary_10_1086_339525 jstor_primary_30137378 istex_primary_ark_67375_HXZ_ZJHVC5LL_M |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2002-04-01 |
PublicationDateYYYYMMDD | 2002-04-01 |
PublicationDate_xml | – month: 04 year: 2002 text: 2002-04-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Chicago, IL |
PublicationPlace_xml | – name: Chicago, IL – name: United States |
PublicationTitle | The Journal of infectious diseases |
PublicationTitleAbbrev | The Journal of Infectious Diseases |
PublicationTitleAlternate | The Journal of Infectious Diseases |
PublicationYear | 2002 |
Publisher | The University of Chicago Press University of Chicago Press |
Publisher_xml | – name: The University of Chicago Press – name: University of Chicago Press |
SSID | ssj0004367 |
Score | 2.2397327 |
Snippet | A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate... |
SourceID | proquest pubmed pascalfrancis crossref oup jstor istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 927 |
SubjectTerms | Bacteriology Biological and medical sciences Carrier State - microbiology Carrier State - prevention & control Child care Child Day Care Centers Child, Preschool Children Conjugate vaccines Control groups Day care centers Double-Blind Method Female Fundamental and applied biological sciences. Psychology Humans Infant Major Articles Male Microbiology Nasopharynx - microbiology Otitis media Permeability, membrane transport, intracellular transport Pneumococcal Infections - microbiology Pneumococcal Infections - prevention & control Pneumococcal vaccine Pneumococcal Vaccines - administration & dosage Pneumococcal Vaccines - immunology Serotyping Streptococcus pneumoniae Streptococcus pneumoniae - classification Streptococcus pneumoniae - immunology Streptococcus pneumoniae - isolation & purification Toddlers Vaccination Vaccines, Conjugate - administration & dosage Vaccines, Conjugate - immunology |
Title | Reduction of Nasopharyngeal Carriage of Streptococcus pneumoniae after Administration of a 9-Valent Pneumococcal Conjugate Vaccine to Toddlers Attending Day Care Centers |
URI | https://api.istex.fr/ark:/67375/HXZ-ZJHVC5LL-M/fulltext.pdf https://www.jstor.org/stable/30137378 https://www.ncbi.nlm.nih.gov/pubmed/11920317 https://www.proquest.com/docview/18411131 https://www.proquest.com/docview/71547627 |
Volume | 185 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1573-6613 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004367 issn: 0022-1899 databaseCode: KQ8 dateStart: 19970401 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1573-6613 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0004367 issn: 0022-1899 databaseCode: DIK dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1573-6613 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004367 issn: 0022-1899 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKJhASQjAYdMDwA_BSZWrjJE4epwKrpnYg6KqqL5GTOFUZpFWbVpRvxAfhe3Fn5y-jCHiJqsSxTr2f4_Pd7-4IeWEK04xiJIVZcNKxpLQMtFoN6dgBCyLHk0KxfC-c3qV1PrbHjcaPCmtpnQYn4bff5pX8j1bhHugVs2T_QbPFpHADfoN-4Qoahutf6fgD1l3NTb4LgR0JxHKbTLFYcFcsQQLtEsDQ8yKdw7cvXK9ai0SuQcSZkFmH8HoBXZ0x6RkjgRtS670aja8qN0PyaY2Ot9ZIhBiSR9N1OEcfx3LVOk3RoY6-h9diqzKblPM449jnJnCZjJbVq9BsMBAsCxZVWt1PsyhVyRU4m23midEXm5mOOk2LbWUivswU_N5VKKofZ1drkM0oslAGcik2NVeHWWHIlGVz_0RVydMTOq7uulR-4u0Klnnlg-3pygTZ3u_pYizXtpW2inIx5tk6S_uXEt0M6zYy7t4g-yZ3HGykcTYumUYWc3hetB4lq7S40lPWbKJ9XN5fc3psnnd5ZyFWoOdYd1vZfRxSZtHwHrmbKZKeanDeJw2ZHJCbusPp9oDcGmTcjQfke4FWOo9pHa00Rys-qqGVlmilCq20jlZ8QdAcrbSKVlqglWZopemc5milBVopoBUFkDRD60Ny-fbNsNszskYhRghfmNTgWKSw43IexJIzlwsZBXAuCEUUOFZgSrC4zEh2Yi9ud0IbrDEcYYJp6zIuvChmh2QvmSfyMaHCtbkVSodhJcTI5iJ27ZhJGfLACZ121CQvc1X5YVZFH5u5fPYVm8N1fK3SJnlejFvoujHXRrxSmi4ei-UVsiy57ffGE39y3ht17X7fHzTJoYJCMTCHW5McATZ2Tn9cg0w5jNmeA_8VSJhjyIctBeOEIpGw2v2Oa4EFxDq7R3A4eIEVBXM80uArZ4cTI9gJ_GiX0E_I7XJpPyV76XItn4FdnwbHatX8BETN_z0 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduction+of+Nasopharyngeal+Carriage+of+Streptococcus+pneumoniae+after+Administration+of+a+9-Valent+Pneumococcal+Conjugate+Vaccine+to+Toddlers+Attending+Day+Care+Centers&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Dagan%2C+Ron&rft.au=Givon-Lavi%2C+Noga&rft.au=Zamir%2C+Orly&rft.au=Sikuler-Cohen%2C+Merav&rft.date=2002-04-01&rft.pub=University+of+Chicago+Press&rft.issn=0022-1899&rft.volume=185&rft.issue=7&rft.spage=927&rft.epage=936&rft_id=info:doi/10.1086%2F339525&rft.externalDocID=30137378 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon |